SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers
13 references·7 citing·40 second hop
On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers (2015)On-the-Road Driving Performance the Morni…Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials (2014)Suvorexant in Patients With I…Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial (2014)Safety and efficacy of suvore…Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men (2013)Effects of Suvorexant, an Ore…Orexin receptor antagonism for treatment of insomnia (2012)Orexin receptor antagonism fo…Next-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult Subjects (2011)Next-Day Effects of Ramelteon…Discovery of the Dual Orexin Receptor Antagonist [(7 R )-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2 H -1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia (2010)Discovery of the Dual Orexin …The hyperarousal model of insomnia: A review of the concept and its evidence (2009)The hyperarousal model of ins…Highway driving performance and cognitive functioning the morning after bedtime and middle‐of‐the‐night use of gaboxadol, zopiclone and zolpidem (2009)Highway driving performance a…Residual Effects of Hypnotics (2004)Residual Effects of HypnoticsDifferential Residual Effects of Zaleplon and Zopiclone on Actual Driving: a Comparison with a Low Dose of Alcohol (2002)Differential Residual Effects…Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance (1998)Residual effects of evening a…The use of analogue scales in rating subjective feelings (1974)The use of analogue scales in…L’examen Clinique en Psychologie (1959)L’examen Clinique en Psycholo…Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations (2023)Targeting Orexin Receptors fo…Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials (2020)Lack of residual morning effe…Zolpidem and Gender: Are Women Really At Risk? (2019)Zolpidem and Gender: Are Wome…Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications (2018)Orexin receptor antagonists f…Pharmacological Treatment of Insomnia (2016)Pharmacological Treatment of …On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly (2016)On-the-road driving performan…Mortality Risk of Hypnotics: Strengths and Limits of Evidence (2015)Mortality Risk of Hypnotics: …Residual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Ability, Memory Functions, and Psychomotor Performance (2002)An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia (2005)Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia (2007)The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: A systematic review and meta-analysis (2014)Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians (2015)Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders (2020)ECDEU Assessment Manual for Psychopharmacology (1976)Validation of the Insomnia Severity Index as an outcome measure for insomnia research (2001)Diagnostic and Statistical Manual of Mental Disorders (2013)Review of Safety and Efficacy of Sleep Medicines in Older Adults (2016)S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen (2017)Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery (2018)A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects (1968)Chronic insomnia (2012)Diagnostic and Statistical Manual of Mental Disorders (2013)Sleep and mental disorders: A meta-analysis of polysomnographic research. (2016)Insomnia as a predictor of mental disorders: A systematic review and meta-analysis (2018)Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents (2008)Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? (2014)Subjective and Objective Sleepiness in the Active Individual (1990)Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data (2015)Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials (2016)The orexin story and orexin receptor antagonists for the treatment of insomnia (2023)The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults (2011)Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians (2016)The assessment and management of insomnia: an update (2019)Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials (2022)The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications (2007)Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR ) (2010)Insomnia and Its Treatment (1985)Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. (1999)Arzneimittelforschung (2015)Internet-Based Cognitive Behavioral Therapy for Insomnia (ICBT-i) Improves Comorbid Anxiety and Depression—A Meta-Analysis of Randomized Controlled Trials (2015)On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers (2018)Sensitivity and accuracy of the visual analogue scale: a psycho‐ physical classroom experiment. (1978)Clinical applications of visual analogue scales: a critical review (1988)Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder (2010)Neuropsychological assessment. (1995)Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability (1998)Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs (2006)
this work references cited by second hop

References

  • 1959L’examen Clinique en Psychologie3,302 cited
  • 1974The use of analogue scales in rating subjective feelings1,977 cited
  • 2009The hyperarousal model of insomnia: A review of the concept and its evidence1,786 cited
  • 2014Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial519 cited
  • 2010Discovery of the Dual Orexin Receptor Antagonist [(7 R )-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2 H -1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia379 cited
  • 2012Orexin receptor antagonism for treatment of insomnia322 cited
  • 2014Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials301 cited
  • 2004Residual Effects of Hypnotics278 cited
  • 2013Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men162 cited
  • 2011Next-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult Subjects137 cited
  • 2002Differential Residual Effects of Zaleplon and Zopiclone on Actual Driving: a Comparison with a Low Dose of Alcohol122 cited
  • 2009Highway driving performance and cognitive functioning the morning after bedtime and middle‐of‐the‐night use of gaboxadol, zopiclone and zolpidem101 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1998
Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance
94 cited

Cited by

  • 2019Zolpidem and Gender: Are Women Really At Risk?75 cited
  • 2016Pharmacological Treatment of Insomnia68 cited
  • 2015Mortality Risk of Hypnotics: Strengths and Limits of Evidence66 cited
  • 2023Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations64 cited
  • 2020Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials54 cited
  • 2018Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications53 cited
  • 2016On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly52 cited